April 2, 2026

Science Chronicle

A Science and Technology Blog

April 2, 2026

Science Chronicle

A Science and Technology Blog

Vaccines

COVID-19HealthResearchVaccine hesitancyVaccines

ICMR study finds the drivers of COVID-19 vaccine hesitancy

Of the 600 participants studied, 524 (87.3%) had taken only one dose of the COVID-19 vaccine, while the remaining 76

Read More
PublishingResearch IntegrityScienceVaccines

BHU’s Covaxin safety study riddled with major limitations

If the most glaring limitation of the study is the lack of a control group, the absence of data on

Read More
CancerCervical cancerVaccines

Serum’s HPV vaccine non-inferior to Gardasil

A phase-2/3 trial of Serum Institute of India’s human papillomavirus (HPV) vaccine Cervavac conducted at 12 tertiary care hospitals across

Read More
Communicable diseaseImmunisationPublic HealthTuberculosis (TB)Vaccines

TB prevention: BCG revaccination study in high-risk adults to begin in 23 States

Since the government felt that a trial would take too long to complete and wanted to implement BCG revaccination at

Read More
Communicable diseaseMalariaPublic HealthVaccines

Now a more efficacious, inexpensive malaria vaccine

The R21/MatrixM malaria vaccine developed by the University of Oxford, manufactured by the Serum Institute of India, has been recommended

Read More
Clinical trialHealthHuman challenge studiesResearch

Are human challenge studies effective? 

Are human studies more challenging than clinical trials, and what are the benefits in a country where the burden of infectious diseases is high?

Read More
Clinical trialHealthHuman challenge studies

ICMR takes the first step in Controlled Human Infection Studies

In the last 50 years, CHIS studies have been carried out with thousands to accelerate vaccine development against typhoid and cholera

Read More
Communicable diseaseHealthPolioPublic HealthPublic health policyTuberculosis (TB)

The case for India switching from the oral to the inactivated polio vaccine

As long as wild poliovirus is present and any country continues to use the oral vaccine, the risk of polio emergence is real in a globalised village

Read More
Communicable diseaseHealthPolioPublic HealthPublic health policy

Unethical for India to continue using polio-causing oral vaccine

Switching from trivalent to bivalent OPV vaccine and introducing one dose of IPV was supposed to eliminate all type 2 vaccine-derived poliovirus cases, but such cases only increased sharply

Read More
Communicable diseaseHealthPublic HealthVaccines

FDA approves first vaccine for respiratory syncytial virus

On May 3, FDA approved the first vaccine — Arexvy — for respiratory syncytial virus (RSV) to lower respiratory tract disease in people older than 60 years

Read More
Communicable diseasePolioPublic HealthPublic health policy

Global polio targets set for 2023 unlikely to be met

Since 1988, when the World Health Assembly established the Global Polio Eradication Initiative (GPEI), wild poliovirus subtype-2 and subtype-3 have

Read More
InfluenzaResearch

Influenza virus might have marine origin with fish as early host

Influenza viruses can infect all classes of fish, and Siberian sturgeon may have served as early, if not the first, hosts of influenza virus before it spilled over into mammals

Read More
CoronavirusomicronPublic HealthSARS-CoV-2Testing

No cause for alarm: On the Omicron recombinant XBB.1.16 in India

More than three years after the pandemic began, newer variants, an uptick in cases, hospitalisations, and even deaths are being reported from

Read More